Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

被引:15
作者
Cartotto, Robert [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Dept Surg, Room D712,1075 Bayview Ave, Toronto, ON M4N 3M5, Canada
关键词
Toxic epidermal necrolysis; Stevens-Johnson syndrome; Burn center; Exfoliative conditions; INTRAVENOUS IMMUNOGLOBULIN; HLA-B-ASTERISK-1502; ALLELE; ERYTHEMA MULTIFORME; CLINICAL-PATTERNS; FAS LIGAND; REQUIREMENTS; CYCLOSPORINE; EXPERIENCE; MANAGEMENT; MORTALITY;
D O I
10.1016/j.cps.2017.02.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, life-threatening, cutaneous drug reactions. Medications are the most common cause, although an infection may be responsible. A link between genetics and certain medications has been established. Clinical diagnosis should be confirmed with biopsy. When the area of epidermal detachment approaches 30%, burn center care is advisable. An ophthalmologist should be consulted to optimize ocular care. Pharmacologic interruption has been sought but there is little consensus on the most appropriate agent and no high-quality studies have been conducted to demonstrate if any of these agents lead to improved survival.
引用
收藏
页码:583 / +
页数:14
相关论文
共 63 条
  • [51] Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR study
    Schneck, Juergen
    Fagot, Jean-Paul
    Sekula, Peggy
    Sassolas, Bruno
    Roujeau, Jean Claude
    Mockenhaupt, Maja
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (01) : 33 - 40
  • [52] A 10-year experience with toxic epidermal necrolysis
    Schulz, JT
    Sheridan, RL
    Ryan, CM
    MacKool, B
    Tompkins, RG
    [J]. JOURNAL OF BURN CARE & REHABILITATION, 2000, 21 (03): : 199 - 204
  • [53] What Are the Fluid Requirements in Toxic Epidermal Necrolysis?
    Shiga, Sarah
    Cartotto, Rob
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2010, 31 (01) : 100 - 104
  • [54] Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis
    Shortt, R
    Gomez, M
    Mittman, N
    Cartotto, R
    [J]. JOURNAL OF BURN CARE & REHABILITATION, 2004, 25 (03): : 246 - 255
  • [55] SOWDER L L, 1990, Journal of Burn Care and Rehabilitation, V11, P237, DOI 10.1097/00004630-199005000-00010
  • [56] Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS']JS): Experience with high-dose intravenous immunoglobulins and topical conservative approach - A retrospective analysis
    Stella, Maurizio
    Clemente, Alessandra
    Bollero, Daniele
    Risso, Daniela
    Dalmasso, Paola
    [J]. BURNS, 2007, 33 (04) : 452 - 459
  • [57] Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis A Systematic Review and Meta-analysis
    Tangamornsuksan, Wimonchat
    Chaiyakunapruk, Nathorn
    Somkrua, Ratchadaporn
    Lohitnavy, Manupat
    Tassaneeyakul, Wichittra
    [J]. JAMA DERMATOLOGY, 2013, 149 (09) : 1025 - 1032
  • [58] Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis
    Valeyrie-Allanore, L.
    Wolkenstein, P.
    Brochard, L.
    Ortonne, N.
    Maitre, B.
    Revuz, J.
    Bagot, M.
    Roujeau, J. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) : 847 - 853
  • [59] Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
    Viard, I
    Wehrli, P
    Bullani, R
    Schneider, P
    Holler, N
    Salomon, D
    Hunziker, T
    Saurat, JH
    Tschopp, J
    French, LE
    [J]. SCIENCE, 1998, 282 (5388) : 490 - 493
  • [60] Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
    Wolkenstein, P
    Latarjet, J
    Roujeau, JC
    Duguet, C
    Boudeau, S
    Vaillant, L
    Maignan, M
    Schuhmacher, MH
    Milpied, B
    Pilorget, A
    Bocquet, H
    Brun-Buisson, C
    Revuz, J
    [J]. LANCET, 1998, 352 (9140) : 1586 - 1589